Parkinson's Disease Posts on Medivizor
Navigation Menu

Parkinson’s Disease Posts on Medivizor

Evaluating the effectiveness and safety of continuous subcutaneous night-time only apomorphine for the treatment of insomnia in patients with Parkinson’s disease.

Evaluating the effectiveness and safety of continuous subcutaneous night-time only apomorphine for the treatment of insomnia in patients with Parkinson’s disease.

Posted by on Sep 18, 2022 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of continuous subcutaneous night-time only apomorphine (Apokyn) infusion for the treatment of insomnia in patients with Parkinson’s disease (PD). The data showed that continuous subcutaneous night-time only apomorphine was effective in improving sleep disturbances in patients with...

Read More

Evaluating the effectiveness and safety of opicapone for the treatment of non-motor symptoms in patients with Parkinson’s disease.

Evaluating the effectiveness and safety of opicapone for the treatment of non-motor symptoms in patients with Parkinson’s disease.

Posted by on Sep 1, 2022 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of opicapone (Ongentys) for the treatment of non-motor symptoms in patients with Parkinson's disease (PD). The data showed that opicapone improved the non-motor symptoms and quality of life (QoL) with manageable side effects in patients with PD. Some background Parkinson's disease...

Read More

Evaluating the long-term effectiveness and safety of device-aided therapies for the treatment of real-world patients with advanced Parkinson’s disease.

Evaluating the long-term effectiveness and safety of device-aided therapies for the treatment of real-world patients with advanced Parkinson’s disease.

Posted by on May 31, 2022 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the long-term effectiveness and safety of device-aided therapies (DATs) for the treatment of real-world patients with advanced Parkinson’s disease (PD). The data showed that in the long-term, DATs are well maintained among these patients. Some background Parkinson's disease (PD) is a disorder in which part...

Read More

Evaluating the long-term effects of exercise and regular physical activity in patients with early Parkinson’s disease.

Evaluating the long-term effects of exercise and regular physical activity in patients with early Parkinson’s disease.

Posted by on May 8, 2022 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the long-term effects of exercise and regular physical activity in patients with early Parkinson’s disease (PD). The data showed that in the long-term, the maintenance of high regular physical activity levels and exercise habits were strongly associated with better clinical outcomes of PD symptoms. Some...

Read More

Evaluating the effectiveness and safety of ropinirole for the treatment of Parkinson’s disease.

Evaluating the effectiveness and safety of ropinirole for the treatment of Parkinson’s disease.

Posted by on Feb 27, 2022 in Parkinson's Disease | 0 comments

In a nutshell This study evaluated the effectiveness and safety of ropinirole (Requip) for the treatment of patients with Parkinson’s disease (PD). The data showed that ropinirole was effective in improving motor function and daily living of patients with PD but was associated with an increase in side effects. Some background Parkinson's...

Read More

Is AADC gene therapy a valuable option for patients with moderately advanced Parkinson Disease?

Is AADC gene therapy a valuable option for patients with moderately advanced Parkinson Disease?

Posted by on Dec 31, 2021 in Parkinson's Disease | 0 comments

In a nutshell In this work, the authors studied whether VY-AADC01 (NBIb-1817) gene therapy was safe and effective in patients with moderately advanced Parkinson's disease (PD) patients with motor fluctuations. The authors showed that this treatment caused an improvement in motor function, quality of life, and a decrease in the level of...

Read More

Have COVID-19 restrictions negatively affected people with Parkinson’s disease?

Have COVID-19 restrictions negatively affected people with Parkinson’s disease?

Posted by on Sep 12, 2021 in Parkinson's Disease | 0 comments

In a nutshell This study looked at how motor symptoms progressed in patients with Parkinson's disease (PD), before and during the COVID-19 pandemic. It found that motor symptoms progressed more quickly during the first 15 months of the pandemic than during the 15 months before it. Some background PD symptoms involving muscles and...

Read More

Can deep brain stimulation improve stomach problems in patients with Parkinson’s disease?

Can deep brain stimulation improve stomach problems in patients with Parkinson’s disease?

Posted by on Aug 27, 2021 in Parkinson's Disease | 0 comments

In a nutshell This study looked at the effectiveness of deep brain stimulation (DBS) in patients with Parkinson's disease (PD) and stomach problems. It found that DBS was associated with an improvement in stomach disorders and a reduced need for medication. Some background PD is a neurologic condition that can be difficult to treat as...

Read More